Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker JAZZ
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Bruce Cozadd Director | JAZZ Jazz Pharmaceuticals plc | 68,808 | $16.2M | — | Nov 6, 2026 | Form 4 ↗ 4 days later · 68,808 shares | Form 144 ↗ |
| Nov 4, 2026 | Patricia Carr Officer | JAZZ Jazz Pharmaceuticals plc | 1,413 | $326.9K | — | Nov 4, 2026 | Form 4 ↗ 2 days later · 1,413 shares | Form 144 ↗ |
| Nov 3, 2026 | Renee D Gala Officer, Director | JAZZ Jazz Pharmaceuticals plc | 1,000 | $225.4K | 10b5-1 | Nov 3, 2026 | Form 4 ↗ 2 days later · 1,000 shares | Form 144 ↗ |
| Nov 2, 2026 | Bruce C Cozadd Officer | JAZZ Jazz Pharmaceuticals plc | 6,000 | $1.3M | 10b5-1 | Nov 2, 2026 | Form 4 ↗ 2 days later · 6,000 shares | Form 144 ↗ |
| Oct 8, 2026 | Anne O'Riordan Director | JAZZ Jazz Pharmaceuticals plc | 14,687 | $3.4M | — | Oct 8, 2026 | — | Form 144 ↗ |
| Oct 6, 2026 | Renee D Gala Officer | JAZZ Jazz Pharmaceuticals plc | 2,000 | $472.8K | 10b5-1 | Oct 6, 2026 | Form 4 ↗ 30 days later · 1,000 shares | Form 144 ↗ |
| Oct 1, 2026 | Bruce C Cozadd Officer | JAZZ Jazz Pharmaceuticals plc | 6,000 | $1.4M | 10b5-1 | Oct 1, 2026 | Form 4 ↗ 34 days later · 6,000 shares | Form 144 ↗ |
| Sep 10, 2026 | Neena Patil Officer | JAZZ Jazz Pharmaceuticals plc | 1,200 | $289.1K | 10b5-1 | Sep 10, 2026 | Form 4 ↗ 4 days later · 1,200 shares | Form 144 ↗ |
| Sep 8, 2026 | Mary Elizabeth Henderson Director | JAZZ Jazz Pharmaceuticals plc | 2,691 | $664.2K | — | Sep 8, 2026 | — | Form 144 ↗ |
| Sep 8, 2026 | Renee D Gala Officer | JAZZ Jazz Pharmaceuticals plc | 2,000 | $486.1K | 10b5-1 | Sep 8, 2026 | Form 4 ↗ 2 days later · 2,000 shares | Form 144 ↗ |
| Sep 1, 2026 | Bruce C Cozadd Officer | JAZZ Jazz Pharmaceuticals plc | 6,000 | $1.5M | 10b5-1 | Sep 1, 2026 | Form 4 ↗ 1 day later · 6,000 shares | Form 144 ↗ |
| Aug 31, 2026 | Patrick Kennedy Director | JAZZ Jazz Pharmaceuticals plc | 3,507 | $857.6K | — | Aug 31, 2026 | — | Form 144 ↗ |
| Aug 31, 2026 | Mary Elizabeth Henderson Director | JAZZ Jazz Pharmaceuticals plc | 3,852 | $942.0K | — | Aug 31, 2026 | — | Form 144 ↗ |
| Aug 31, 2026 | Mark Douglas Smith Director | JAZZ Jazz Pharmaceuticals plc | 3,507 | $857.6K | — | Aug 31, 2026 | — | Form 144 ↗ |
| Aug 31, 2026 | Jennifer E. Cook Director | JAZZ Jazz Pharmaceuticals plc | 3,507 | $857.6K | — | Aug 31, 2026 | — | Form 144 ↗ |
| Aug 31, 2026 | Laura Hamill Director | JAZZ Jazz Pharmaceuticals plc | 3,507 | $857.6K | — | Aug 31, 2026 | — | Form 144 ↗ |
| Aug 31, 2026 | Heather Ann McSharry Director | JAZZ Jazz Pharmaceuticals plc | 3,507 | $857.6K | — | Aug 31, 2026 | — | Form 144 ↗ |
| Aug 31, 2026 | Rick E. Winningham Director | JAZZ Jazz Pharmaceuticals plc | 3,507 | $857.6K | — | Aug 31, 2026 | — | Form 144 ↗ |
| Aug 31, 2026 | Patrick G. Enright Director | JAZZ Jazz Pharmaceuticals plc | 3,507 | $857.6K | — | Aug 31, 2026 | — | Form 144 ↗ |
| Aug 31, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | 2,506 | $612.8K | — | Aug 31, 2026 | Form 4 ↗ 2 days later · 6,000 shares | Form 144 ↗ |
| Aug 31, 2026 | Ted W. Love Director | JAZZ Jazz Pharmaceuticals plc | 1,527 | $373.4K | — | Aug 31, 2026 | — | Form 144 ↗ |
| Aug 31, 2026 | Norbert G. Riedel Director | JAZZ Jazz Pharmaceuticals plc | 3,507 | $857.6K | — | Aug 31, 2026 | — | Form 144 ↗ |
| Aug 27, 2026 | Robert Iannone Officer | JAZZ Jazz Pharmaceuticals plc | 76,921 | $19.2M | 10b5-1 | Aug 27, 2026 | Form 4 ↗ 4 days later · 76,921 shares | Form 144 ↗ |
| Aug 7, 2026 | ORiordan Anne Director | JAZZ Jazz Pharmaceuticals plc | 3,507 | $882.3K | — | Aug 7, 2026 | — | Form 144 ↗ |
| Aug 3, 2026 | Bruce C Cozadd Officer | JAZZ Jazz Pharmaceuticals plc | 6,000 | $1.5M | 10b5-1 | Aug 3, 2026 | Form 4 ↗ 2 days later · 6,000 shares | Form 144 ↗ |
| Jul 1, 2026 | Bruce C Cozadd Officer | JAZZ Jazz Pharmaceuticals plc | 6,000 | $1.4M | 10b5-1 | Jul 1, 2026 | Form 4 ↗ 5 days later · 6,000 shares | Form 144 ↗ |
| Jun 15, 2026 | Mark D Smith Director | JAZZ Jazz Pharmaceuticals plc | 1,157 | $266.7K | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 2 days later · 1,157 shares | Form 144 ↗ |
| Jun 10, 2026 | Neena Patil Officer | JAZZ Jazz Pharmaceuticals plc | 1,200 | $278.2K | 10b5-1 | Jun 10, 2026 | Form 4 ↗ 2 days later · 1,200 shares | Form 144 ↗ |
| Jun 1, 2026 | Bruce C Cozadd Officer | JAZZ Jazz Pharmaceuticals plc | 6,000 | $1.4M | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 2 days later · 6,000 shares | Form 144 ↗ |
| May 28, 2026 | Neena Patil Officer | JAZZ Jazz Pharmaceuticals plc | 1,192 | $282.5K | 10b5-1 | May 28, 2026 | Form 4 ↗ 4 days later · 1,192 shares | Form 144 ↗ |
| May 28, 2026 | Samantha Pearce Officer | JAZZ Jazz Pharmaceuticals plc | 6,907 | $1.6M | — | May 28, 2026 | Form 4 ↗ 4 days later · 6,907 shares | Form 144 ↗ |
| May 22, 2026 | Heather McSharry Director | JAZZ Jazz Pharmaceuticals plc | 2,000 | $482.0K | — | May 22, 2026 | Form 4 ↗ 5 days later · 2,000 shares | Form 144 ↗ |
| May 22, 2026 | Rick Winningham Director | JAZZ Jazz Pharmaceuticals plc | 2,741 | $662.1K | — | May 22, 2026 | Form 4 ↗ 5 days later · 2,741 shares | Form 144 ↗ |
| May 1, 2026 | Bruce C Cozadd Officer | JAZZ Jazz Pharmaceuticals plc | 6,000 | $1.2M | 10b5-1 | May 1, 2026 | Form 4 ↗ 4 days later · 6,000 shares | Form 144 ↗ |
| Apr 1, 2026 | Bruce C Cozadd Officer | JAZZ Jazz Pharmaceuticals plc | 6,000 | $1.1M | 10b5-1 | Apr 1, 2026 | Form 4 ↗ 2 days later · 6,000 shares | Form 144 ↗ |
| Mar 9, 2026 | Patricia Carr Officer | JAZZ Jazz Pharmaceuticals plc | 1,287 | $235.4K | — | Mar 9, 2026 | Form 4 ↗ same day · 1,287 shares | Form 144 ↗ |
| Mar 5, 2026 | Mary Elizabeth Henderson Officer | JAZZ Jazz Pharmaceuticals plc | 2,643 | $498.7K | — | Feb 26, 2026 | — | Form 144 ↗ |
| Mar 5, 2026 | Patricia Carr Officer | JAZZ Jazz Pharmaceuticals plc | 2,723 | $513.8K | — | Mar 5, 2026 | Form 4 ↗ 4 days later · 1,287 shares | Form 144 ↗ |
| Mar 3, 2026 | Bruce C Cozadd Officer | JAZZ Jazz Pharmaceuticals plc | 6,000 | $1.1M | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 1 day later · 6,000 shares | Form 144 ↗ |
| Feb 27, 2026 | Patricia Carr Officer | JAZZ Jazz Pharmaceuticals plc | 1,117 | $213.2K | — | Feb 27, 2026 | Form 4 ↗ 3 days later · 2,370 shares | Form 144 ↗ |
| Feb 27, 2026 | Norbert Riedel Director | JAZZ Jazz Pharmaceuticals plc | 3,415 | $655.7K | — | Feb 27, 2026 | Form 4 ↗ 3 days later · 3,415 shares | Form 144 ↗ |
| Feb 26, 2026 | Mary Elizabeth Henderson Officer | JAZZ Jazz Pharmaceuticals plc | 10,116 | $2.0M | — | Feb 26, 2026 | Form 4 ↗ 4 days later · 5,343 shares | Form 144 ↗ |
| Feb 26, 2026 | Neena Patil Officer | JAZZ Jazz Pharmaceuticals plc | 55,600 | $10.7M | — | Feb 26, 2026 | Form 4 ↗ 4 days later · 55,600 shares | Form 144 ↗ |
| Feb 26, 2026 | Patricia Carr Officer | JAZZ Jazz Pharmaceuticals plc | 2,370 | $466.5K | — | Feb 26, 2026 | Form 4 ↗ 4 days later · 2,370 shares | Form 144 ↗ |
| Dec 9, 2025 | Mary Elizabeth Henderson Officer | JAZZ Jazz Pharmaceuticals plc | 2,238 | $379.4K | — | Dec 9, 2025 | Form 4 ↗ 2 days later · 2,238 shares | Form 144 ↗ |
| Dec 5, 2025 | Patricia Carr Officer | JAZZ Jazz Pharmaceuticals plc | 4,660 | $797.8K | — | Dec 5, 2025 | Form 4 ↗ 4 days later · 4,660 shares | Form 144 ↗ |
| Dec 1, 2025 | Kenneth W. O'Keefe Director | JAZZ Jazz Pharmaceuticals plc | 1,249 | $220.6K | — | Dec 2, 2025 | — | Form 144 ↗ |
| Nov 26, 2025 | Bruce Cozadd Director | JAZZ Jazz Pharmaceuticals plc | 77,500 | $13.8M | — | Nov 26, 2025 | Form 4 ↗ 5 days later · 77,500 shares | Form 144 ↗ |
| Nov 20, 2025 | Heather McSharry Director | JAZZ Jazz Pharmaceuticals plc | 3,415 | $607.1K | — | Nov 20, 2025 | Form 4 ↗ 4 days later · 3,415 shares | Form 144 ↗ |
| Nov 19, 2025 | Mary Elizabeth Henderson Officer | JAZZ Jazz Pharmaceuticals plc | 2,961 | $376.7K | — | Nov 19, 2025 | Form 4 ↗ 22 days later · 2,238 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:33 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances